Two recently issued patents describe new fibrinogen receptor antagonists designed at DuPont July 3, 2000
ZK-807834 effective at lower doses and with less bleeding risk compared to other FXa inhibitors June 27, 2000
Antiplatelet compounds in early development at Welfide superior to cilostazol in activity, safety June 23, 2000
RSS